You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular Targeted Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Checkpoint Inhibitor Monotherapy or Combined With

Not yet recruiting
  • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Pineoblastoma Trial in Regensburg (Temozolomide, Irinotecan, Dasatinib)

Completed
  • Pineoblastoma
  • Regensburg, Germany
    University Hospital of Regensburg
Jul 29, 2021

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Cancer, Solid Tumor, Adult Trial in France (research of druggable molecular alterations on tumor biopsy)

Active, not recruiting
  • Cancer
  • Solid Tumor, Adult
  • research of druggable molecular alterations on tumor biopsy
  • Bordeaux, France
  • +3 more
May 16, 2022

Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)

Recruiting
  • Prostate Cancer
  • PSMA-Targeted [In-111]-Labeled Trillium Compound
  • PTI-122
  • Glen Burnie, Maryland
  • +2 more
Mar 21, 2023

Clinical Resistance to Targeted Therapy Among Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Blood draw
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 22, 2022

Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

Enrolling by invitation
  • Breast Cancer Female
  • Tomsk, Russian Federation
    Olga
Jun 19, 2023

Molecular Imaging in HER2-positive Breast Cancer During

Enrolling by invitation
  • HER2-positive Breast Cancer
  • Female
  • Tomsk, Russian Federation
  • +1 more
Jun 7, 2022

Patients With Advanced Refractory Solid Tumors

Not yet recruiting
  • Feasibility
  • +3 more
  • Targeted therapy
  • (no location specified)
Dec 14, 2021

Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular

Completed
Has Results
  • Gliosarcoma
  • Recurrent Glioblastoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 5, 2022

Evidence Determining Individualized Cancer Therapy for Incurable

Terminated
  • Hematologic Cancer
  • Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
  • La Jolla, California
    UCSD Moore's Cancer Center
Jan 31, 2022

Breast Cancer Female Trial in Tomsk (99mTc-ADAPT6, 99mTc-DARPinG3)

Recruiting
  • Breast Cancer Female
  • Tomsk, Russian Federation
    Tomsk NRMC
May 12, 2022

Neuroblastoma Recurrent Trial in Regensburg (Dasatinib, Rapamycin, Irinotecan)

Completed
  • Neuroblastoma Recurrent
  • Regensburg, Germany
    University Hospital Regensburg, Department of Pediatric Hematolo
Oct 2, 2020

Cancer, Non Small Cell Lung Cancer Trial in Salt Lake City (PET Imaging, Erlotinib, Bevacizumab)

Completed
  • Cancer
  • Non Small Cell Lung Cancer
  • PET Imaging
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Dec 16, 2021

Abdominal Aortic Aneurysm (AAA) Trial in Saint Louis (Aortoiliac Occlusive Disease Group - PET-CT imaging with injection of

Terminated
  • Abdominal Aortic Aneurysm (AAA)
  • Aortoiliac Occlusive Disease Group - PET-CT imaging with injection of 64Cu-DOTA-ECL1i
  • AAA Group- PET-CT imaging with injection of 64Cu-DOTA-ECL1i
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 9, 2022

PFS and OS of Advanced Neuroendocrine Cancer After Systemic

Recruiting
  • Neuroendocrine Tumors
    • Olsztyn, Warmińsko-Mazurskie, Poland
    • +1 more
    May 12, 2021

    Hepatocellular Carcinoma, Immunotherapy, Molecular Targeted Therapy Trial in Shanghai (Camrelizumab, Apatinib Mesylate, TACE

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Shanghai, Shanghai, China
      180 Fenglin Road
    Apr 25, 2021

    Hepatocellular Carcinoma, Molecular Targeted Therapy Trial in Shanghai (Lenvatinib and Gefitinib)

    Unknown status
    • Hepatocellular Carcinoma
    • Molecular Targeted Therapy
    • Lenvatinib and Gefitinib
    • Shanghai, Shanghai, China
      Renji Hospital, School of Medicine, Shanghai Jiaotong University
    Jan 13, 2021

    Treatment Efficacy in Patients With Ovarian Cancer

    Not yet recruiting
    • High-grade Serous Ovarian Cancer
    • Circulating Tumor DNA
      • (no location specified)
      Aug 25, 2021

      Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

      Not yet recruiting
      • Recurrent Endometrial Carcinoma
      • Recurrent Ovarian Carcinoma
      • Biopsy
      • +5 more
      • (no location specified)
      Sep 29, 2022

      Metastatic Renal Cell Carcinoma Trial in Shanghai (sunitinib or pazopanib, PD-1 inhibitor combined with axitinib)

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • sunitinib or pazopanib
      • PD-1 inhibitor combined with axitinib
      • Shanghai, Shanghai, China
        Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
      Apr 16, 2023

      Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

      Active, not recruiting
      • Prostate Cancer
      • Abiraterone Acetate
      • +3 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Dec 6, 2022

      Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

      Completed
      • Colorectal Cancer Metastatic
      • Targeted agent
      • (no location specified)
      Aug 31, 2023